ZP General Partner 3 ApS: Financial statements 2025
CVR: 41023422
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ZP General Partner 3 ApS (CVR 41023422) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,000 and a net result of DKK -29,000 compared with DKK -18,000 the year before. That is a decrease of 50% compared with the year before. The profit margin was -2,900%. Equity in the 2025 report amounted to DKK 30,000. The solvency ratio was 44.8%.
- Revenue
- DKK 1,000
- Gross Profit
- DKK 1,000
- Profit/Loss
- DKK -29,000
- Equity
- DKK 30,000
- Total Assets
- DKK 67,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 1K | 1K | -29K | 30K | - |
| 2024 | 2K | 2K | -18K | -10K | - |
| 2023 | 1K | 1K | -14K | 8K | - |
| 2022 | 1K | 1K | -24K | 22K | - |
| 2021 | 0 USD | 0 USD | -1K USD | 7K USD | - |
Official annual report
How creditworthy is ZP General Partner 3 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ZP General Partner 3 ApS has published its annual report for 2024. Revenue came to DKK 2,000, and the net result was DKK -18,000.
About ZP General Partner 3 ApS
ZP General Partner 3 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported revenue of DKK 1,000 and a net result of DKK -29,000 compared with DKK -18,000 the year before. Equity in the 2025 report amounted to DKK 30,000.